Molecular genetic defects in congenital hypothyroidism

Eur J Endocrinol. 2004 Nov:151 Suppl 3:U39-44. doi: 10.1530/eje.0.151u039.

Abstract

Recently molecular genetic defects in some cases of congenital hypothyroidism (CH) as well as of rare cases of central hypothyroidism have been identified. These studies have led to the description of so far unexplained forms of these disorders. In some patients with CH early diagnosis by newborn screening and early treatment was not able to lead to a normal mental development. This could subsequently be explained by molecular defects of transcription factors (FOXE-1/FKHL15, NKX2.1) which are important not only for the embryonic development of the thyroid gland but also for other organs including the central nervous system (CNS). These findings will help in understanding the critical role of thyroid hormones in the pre-and postnatal CNS development. However, many questions regarding the molecular defects and their consequences in the majority of patients with CH still remain open and will be addressed in this article.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Central Nervous System / embryology
  • Congenital Hypothyroidism*
  • Female
  • Homeodomain Proteins / genetics
  • Humans
  • Hypothalamus / abnormalities
  • Hypothyroidism / genetics*
  • LIM-Homeodomain Proteins
  • Mice
  • Pituitary Gland / abnormalities
  • Thyroid Gland / abnormalities
  • Thyroid Gland / embryology
  • Transcription Factors / genetics

Substances

  • Homeodomain Proteins
  • LIM-Homeodomain Proteins
  • Lhx3 protein
  • Prophet of Pit-1 protein
  • Transcription Factors